Cargando…
Therapeutic Role of Recombinant Human Soluble Thrombomodulin for Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is an acute respiratory worsening of unidentifiable cause that sometimes develops during the clinical course of IPF. Although the incidence of AE-IPF is not high, prognosis is poor. The pathogenesis of AE-IPF is not well understood; howeve...
Autores principales: | Isshiki, Takuma, Sakamoto, Susumu, Homma, Sakae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571552/ https://www.ncbi.nlm.nih.gov/pubmed/31137593 http://dx.doi.org/10.3390/medicina55050172 |
Ejemplares similares
-
The Activities of Daily Living after an Acute Exacerbation of Idiopathic Pulmonary Fibrosis
por: Koyama, Kazuya, et al.
Publicado: (2017) -
Association of serum high-mobility group box protein 1 level with outcomes of acute exacerbation of idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia
por: Shimizu, Hiroshige, et al.
Publicado: (2018) -
Reply to Horita and Takeshi: Thrombomodulin Did Not Benefit Acute Exacerbation of Idiopathic Pulmonary Fibrosis in a Trial
por: Kondoh, Yasuhiro, et al.
Publicado: (2020) -
New risk scoring system for predicting 3-month mortality after acute exacerbation of idiopathic pulmonary fibrosis
por: Sakamoto, Susumu, et al.
Publicado: (2022) -
Recombinant human soluble thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis: a nationwide observational study
por: Awano, Nobuyasu, et al.
Publicado: (2022)